These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 27506680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.
    Shi RY, An DA, Chen BH, Wu R, Du L, Jiang M, Xu JR, Wu LM.
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.
    Gommans DHF, Cramer GE, Bakker J, Dieker HJ, Michels M, Fouraux MA, Marcelis CLM, Verheugt FWA, Timmermans J, Brouwer MA, Kofflard MJM.
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):113-120. PubMed ID: 29063221
    [Abstract] [Full Text] [Related]

  • 6. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N, Matsumura Y, Furuno T, Sugiura T, Doi YL.
    J Am Coll Cardiol; 2013 Oct 01; 62(14):1252-1259. PubMed ID: 23623916
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y, Pourjafari M, Darabi F, Boroumand MA, Zoroufian A, Jalali A.
    J Cardiol; 2014 Feb 01; 63(2):140-4. PubMed ID: 24011925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.
    Liao H, Tan HC, Wang Z, Chen X, He Y, He S.
    BMC Cardiovasc Disord; 2021 Jul 03; 21(1):325. PubMed ID: 34217206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy.
    Gommans DHF, Cramer GE, Fouraux MA, Heijmans S, Michels M, Timmermans J, Verheugt FWA, de Boer RA, Kofflard MJM, Brouwer MA.
    Am J Cardiol; 2021 Aug 01; 152():120-124. PubMed ID: 34130823
    [Abstract] [Full Text] [Related]

  • 14. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
    Hasler S, Manka R, Greutmann M, Gämperli O, Schmied C, Tanner FC, Biaggi P, Lüscher TF, Keller DI, Gruner C.
    Swiss Med Wkly; 2016 Aug 01; 146():w14285. PubMed ID: 26999566
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
    Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Yamanaka S, Iiyama T, Kumagai N, Furuno T, Sugiura T, Kitaoka H.
    BMC Cardiovasc Disord; 2015 Jun 16; 15():53. PubMed ID: 26077897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Gawor M, Śpiewak M, Kubik A, Wróbel A, Lutyńska A, Marczak M, Grzybowski J.
    Biomarkers; 2018 Nov 16; 23(7):676-682. PubMed ID: 29737871
    [Abstract] [Full Text] [Related]

  • 19. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
    Reinstadler SJ, Feistritzer HJ, Klug G, Mair J, Tu AM, Kofler M, Henninger B, Franz WM, Metzler B.
    Int J Cardiol; 2016 Jan 01; 202():188-93. PubMed ID: 26397408
    [Abstract] [Full Text] [Related]

  • 20. High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy.
    Shi RY, An DA, Chen BH, Wu R, Wu CW, Du L, Zhu J, Jiang M, Xu JR, Wu LM.
    Sci Rep; 2019 Feb 25; 9(1):2644. PubMed ID: 30804397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.